CAS: 1076199-22-8
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
4-Boc-1-(1,4-benzodioxan-2-ylcarbonyl)piperazine REF: IN-DA008VR8CAS: 1076199-22-8 | 95% | 162.00 €~197.00 € | Fri 24 Jan 25 | |
4-Boc-1-(1,4-benzodioxan-2-ylcarbonyl)piperazine REF: TR-B625100CAS: 1076199-22-8 | - - - | 178.00 €~521.00 € | Thu 06 Mar 25 | |
4-(2,3,4a,8a-Tetrahydro-benzo[1,4]dioxine-2-carbonyl)-piperazine-1-carboxylic acid tert-butyl ester REF: 10-F091011CAS: 1076199-22-8 | 95+% | - - - | Discontinued product | |
4-Boc-1-(1,4-benzodioxan-2-ylcarbonyl)piperazine REF: 3D-FB18862CAS: 1076199-22-8 | Min. 95% | - - - | Discontinued product |
4-Boc-1-(1,4-benzodioxan-2-ylcarbonyl)piperazine
CAS:1076199-22-8
Formula:
C18H24N2O5
Purity:
95%
Color and Shape:
Solid
Molecular weight:
348.3936
Ref: IN-DA008VR8
100mg | 162.00 € | ||
250mg | 197.00 € |
Estimated delivery in United States, on Friday 24 Jan 2025
4-Boc-1-(1,4-benzodioxan-2-ylcarbonyl)piperazine
Controlled ProductCAS:1076199-22-8
Applications 4-Boc-1-(1,4-benzodioxan-2-ylcarbonyl)piperazine (cas# 1076199-22-8) is a compound useful in organic synthesis.
Formula:
C18H24N2O5
Color and Shape:
Neat
Molecular weight:
348.39
Ref: TR-B625100
5mg | 178.00 € | ||
10mg | 247.00 € | ||
25mg | 521.00 € |
Estimated delivery in United States, on Thursday 6 Mar 2025
4-(2,3,4a,8a-Tetrahydro-benzo[1,4]dioxine-2-carbonyl)-piperazine-1-carboxylic acid tert-butyl ester
CAS:1076199-22-8
Purity:
95+%
Molecular weight:
348.399
Ref: 10-F091011
500mg | Discontinued | Request information |
4-Boc-1-(1,4-benzodioxan-2-ylcarbonyl)piperazine
CAS:1076199-22-8
Please enquire for more information about 4-Boc-1-(1,4-benzodioxan-2-ylcarbonyl)piperazine including the price, delivery time and more detailed …
Formula:
C18H24N2O5
Purity:
Min. 95%
Molecular weight:
348.39 g/mol
Ref: 3D-FB18862
5mg | Discontinued | Request information | |
10mg | Discontinued | Request information | |
25mg | Discontinued | Request information | |
50mg | Discontinued | Request information | |
100mg | Discontinued | Request information |